In the CKVO 90–11 study, which compared the effectiveness of fluorouracil/levamisole and fluorouracil/levamisole/leucovorin in patients with stage III colon cancer, no relationship was found between KRAS mutation and DFS [63]. The gene discussed is KRAS; the disease is malignant colon neoplasm.